Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) (Frankfurt:YG3) is pleased to announce that it has completed the formulations for 10 new products to be infused with cannabinoids: 4 facial skin care products, 4 essential oil wellness blends and 2 foot creams.

Yield Growth subsidiary Urban Juve is the first to commercialize products containing hemp root oil, which Urban Juve produces using its patent pending extraction technology.  Hemp root oil terpenes have been found to enhance natural absorption of botanicals into the skin.


Urban Juve has developed 4 new skin care products that it intends to add to the Urban Juve product line later this year. These include an eye cream, a makeup remover, a liquid face cleanser and facial cleanser pads. Each of these products has been created using the highest quality natural ingredients.   The Urban Juve makeup remover is a refreshing cream cleanser designed to gently remove the heaviest eye and face makeup in one easy step, leaving skin feeling hydrated and fresh.

Urban Juve has also developed 4 exotic essential oil wellness blends, all containing hemp root oil.  They are tentatively entitled “Energy Boost”, “Headache”, “Sleep” and “Stress”.   Each of the formulas are designed to be easily blended with THC and CBD oils.

“Energy Boost” is intended to boost mood, uplift spirits and reduce fatigue while improving concentration, accuracy and mental clarity.

“Headache” is intended to relieve headache symptoms by relaxing muscles and sinus tension when applied to the temples and nape of the neck.

“Sleep” is intended as a remedy for insomnia, to relieve stress and anxiety and to reduce hypertension when applied to the bottom of the feet.

“Stress” is designed to fight stress and ease discomfort of nervous tension by promoting calm and relief from excessive worrying when applied to wrists and ankles.

Yield Growth subsidiary UJ Topicals has developed two foot creams, with hemp root oil, clay and essential oils, that are created to be infused with cannabinoids. One cream is intended to be infused with CBD to relieve pain and moisturize dry, cracked feet.  The other foot cream is intended to be infused with THC to relieve pain from blisters, bruises, inflammation, sore heels, bunions, corns and calluses.

About The Yield Growth Corp.

The Yield Growth Corp. is dedicated to the rapid and sustainable growth of cannabis wellness assets. Its directors, officers and advisors have C- level experience at multi-billion dollar international companies including M.A.C Cosmetics and Johnson & Johnson and have worked at Aritzia, Procter & Gamble, Skechers, Pepsi and Coca Cola.  Yield Growth’s key assets are 100% owned subsidiaries Urban Juve Provisions Inc., UJ Topicals Inc., UJ Beverages Inc., UJ Edibles Inc. and Thrive Activations Inc.  Through its subsidiaries it owns over 60 wellness formulas for topicals and beverages, has registered 29 products with Health Canada, has applied for 11 U.S. provisional patents and is currently selling products online in the U.S. and Canada and through retailers in Canada. Its subsidiary UJ Topicals is launching THC and CBD products through a distribution network of 400 cannabis retail stores in Oregon, USA.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram.  Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny Green, President & CEO

Kristina Pillon, Investor Relations

invest@yieldgrowth.com

1-833-514-BOSS   1-833-514-2677
1-833-515-BOSS   1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation.  Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements.  Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve, UJ Topicals, UJ Beverages and UJ Edibles products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets.  Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4c40bdd2-21d1-4738-9690-6574b3ff609e

Click here to connect with Yield Growth Corp. (CSE:BOSS) for an Investor Presentation. 

Source: globenewswire.ca

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less